Eva Sum

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Tandem Mass Spectrometry

Dendritic Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Eva Sum, Moritz Rapp, Harald Dürr, Alekhya Mazumdar, Pedro J Romero, Christine Trumpfheller, Pablo Umaña
The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation. Journal for immunotherapy of cancer 10 (3) (2022)
Maud Mayoux, Andreas Roller, Vesna Pulko, Stefano Sammicheli, Stanford Chen, Eva Sum, Christian Jost, Marieke F Fransen, Regula B Buser, Marcin Kowanetz, Karolin Rommel, Ines Matos, Sara Colombetti, Anton Belousov, Vaios Karanikas, Ferry Ossendorp, Priti S Hegde, Daniel C Chen, Pablo Umaña, Mario Perro, Christiane Neumann, Wei Xu
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy. Science translational medicine 12 (534) (2021)
Sara Labiano, Vincent Roh, Céline Godfroid, Agnès Hiou-Feige, Jackeline Romero, Eva Sum, Moritz Rapp, Gael Boivin, Tania Wyss Lozano, Christian Simon, Jean Bourhis, Pablo Umaña, Christine Trumpfheller, Genrich V Tolstonog, Marie-Catherine Vozenin, Pedro Romero
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Eva Sum, Moritz Rapp, Philipp Fröbel, Marine Le Clech, Harald Dürr, Anna Maria Giusti, Mario Perro, Dario Speziale, Leo Kunz, Elena Menietti, Peter Brünker, Ulrike Hopfer, Martin Lechmann, Andrzej Sobieniecki, Birte Appelt, Roberto Adelfio, Valeria Nicolini, Anne Freimoser-Grundschober, Whitney Jordaan, Sara Labiano, Felix Weber, Thomas Emrich, François Christen, Birgit Essig, Pedro Romero, Christine Trumpfheller, Pablo Umaña
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)